Soluble Programmed Cell Death-1 is a Novel Predictor of HBsAg Loss in Chronic Hepatitis B Patients When Long-Term Nucleos(t)ide Analog Treatment is Discontinued.
Guichan LiaoZiying LiuMuye XiaHongjie ChenHouji WuBing LiTao YuShao-Hang CaiXiaoyong ZhangJie PengPublished in: Infection and drug resistance (2022)
EOT sPD-1 levels predicted clinical relapse and HBsAg loss after treatment discontinuation and may help to guide a finite NA treatment plan for patients with chronic hepatitis B virus infection.